Nuvama Institutional Equities

Rediff.com » News » Nuvama Institutional Equities

News for Nuvama Institutional Equities

Business
Movies

Health care, pharma IPOs raise Rs 14,811 cr in 2024

India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding......

Lock-up on nearly Rs 1.2 trillion pre-IPO shares to lift in two months

Lock up on shares worth nearly Rs 1.2 trillion ($14 billion) belonging to 50 companies will end between now and January 31, said Nuvama Institutional Equities in a note. Illustration: Dominic......

Auto revenue may hit high gear on rural push, launches

Overall, volume growth is likely to be in the range of 3-8 per cent for two-wheelers and 5-7 per cent for passenger vehicles owing to healthy demand from urban and rural areas and pending order......

Analysts maintain 'Buy' calls on ICICI Bank after Q3; see up to 32% upside

Defying the bearish sentiment in the markets on Monday, ICICI Bank’s share price rose by 2 per cent, reaching an intraday high of Rs 1,234.4 per share on the BSE. Photograph: Francis......

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy’s Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company’s Q3 performance and......

The Big Change At Karan Johar's Dharma

Industry experts believe that this deal will positively impact the Indian film industry, which is struggling with fewer movie releases. IMAGE: Karan Johar with Adar Poonawalla in Switzerland.......

Rediff News

Nuvama Institutional Equities

News for Nuvama Institutional Equities

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Lock-up on nearly Rs 1.2 trillion pre-IPO shares to lift in two months

Auto revenue may hit high gear on rural push, launches

Analysts maintain 'Buy' calls on ICICI Bank after Q3; see up to 32% upside

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

The Big Change At Karan Johar's Dharma

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS